American Capital Advisory’s GSK GSK Stock Holding History

American Capital Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.35K	Sell	83 -11	-12%	-$582	﹤0.01%	467
2026 Q1	$5.19K	Buy	94 +68	+262%	+$3.69K	﹤0.01%	396
2025 Q4	$1.28K	Hold	26	–	–	﹤0.01%	542
2025 Q3	$1.12K	Buy	+26	New	+$1.02K	﹤0.01%	522

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

American Capital Advisory's GSK Position: Q2 2026 in Review

American Capital Advisory reduced its GSK (GSK) stake by 12% in Q2 2026, selling an estimated $582 and leaving 83 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

American Capital Advisory first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.19K in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

American Capital Advisory held 83 shares of GSK worth $4.35K as of Q2 2026.
American Capital Advisory sold 11 GSK shares in Q2 2026, an estimated $582.
GSK made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #467 holding.
American Capital Advisory first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
American Capital Advisory's GSK position peaked at $5.19K in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.